8-K Announcements
6Material company update
Apr 13, 2026·SEC
Material company update
Mar 3, 2026·SEC
Material company update
Feb 12, 2026·SEC
CVRx, Inc.(CVRX)Earnings, Financials & Key Ratios
CVRX•NASDAQ
$7.32
$192M mkt cap·Price updated May 7, 2026
AboutCVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Show more
- Revenue$57M+10.4%
- EBITDA-$51M+12.9%
- Net Income-$53M+11.1%
- EPS (Diluted)-2.04+23.0%
- Gross Margin85.33%+1.9%
- EBITDA Margin-90.49%+21.2%
- Operating Margin-90.49%+22.0%
- Net Margin-94.1%+19.5%
- ROE-96.59%-18.4%
- ROIC-256.67%+9.3%
- Debt/Equity1.29+82.0%
- Interest Coverage-8.80+35.0%
CVRX Key Insights
CVRx, Inc. (CVRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 56.4%
✗Weaknesses
- ✗Negative free cash flow
- ✗Shares diluted 15.4% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CVRX Price & Volume
CVRx, Inc. (CVRX) stock price & volume — 10-year historical chart
Loading chart...
CVRX Growth Metrics
CVRx, Inc. (CVRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years56.4%
3 Years36.11%
TTM18.44%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM11.04%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM25.19%
Return on Capital
10 Years-39.34%
5 Years-39.17%
3 Years-46.02%
Last Year-47.88%
CVRX Recent Earnings
CVRx, Inc. (CVRX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 6/12 qtrs (50%)
Q1 2026Latest
Feb 12, 2026EPS
$0.46
Est $0.42
-9.5%
Revenue
$16M
Est $16M
+1.6%
Q4 2025
Nov 5, 2025EPS
$0.49
Est $0.50
+2.0%
Revenue
$15M
Est $16M
-6.7%
Q3 2025
Aug 4, 2025EPS
$0.57
Est $0.52
-9.6%
Revenue
$14M
Est $14M
-5.6%
Q2 2025
May 8, 2025EPS
$0.53
Est $0.56
+5.4%
Revenue
$12M
Est $13M
-7.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 12, 2026 | $0.46vs $0.42-9.5% | $16Mvs $16M+1.6% |
| Q4 2025 | Nov 5, 2025 | $0.49vs $0.50+2.0% | $15Mvs $16M-6.7% |
| Q3 2025 | Aug 4, 2025 | $0.57vs $0.52-9.6% | $14Mvs $14M-5.6% |
| Q2 2025 | May 8, 2025 | $0.53vs $0.56+5.4% | $12Mvs $13M-7.3% |
Based on last 12 quarters of dataView full earnings history →
CVRX Peer Comparison
CVRx, Inc. (CVRX) competitors in Neuromodulation and neuro devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LIVN | 3.88B | 70.93 | -15.94 | 10.74% | 7.47% | 9.13% | 0.39 | |
 NVCR | 1.92B | 16.83 | -13.80 | 8.28% | -25.66% | -50.82% | 0.85 | |
 LFST | 3.43B | 8.85 | 442.50 | 13.85% | 1.55% | 1.56% | 0.13 | |
 MDT | 99.94B | 77.96 | 21.60 | 3.62% | 13% | 9.45% | 0.59 | |
 ABT | 151.3B | 87.01 | 11.39 | 4.59% | 31.88% | 27.26% | 0.32 | |
 BSX | 84.08B | 56.58 | 29.16 | 19.87% | 14.4% | 12.4% | 0.51 | |
 AVNT | 3.35B | 36.50 | 41.01 | 0.61% | 4.81% | 6.59% | 0.81 | |
 ELMD | 222.39M | 26.86 | 31.23 | 16.97% | 13.06% | 19.79% | 0.00 |
Compare CVRX vs Peers
CVRx, Inc. (CVRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CVRX Income Statement
CVRx, Inc. (CVRX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 6.26M | 6.05M | 13.04M | 22.47M | 39.3M | 51.29M | 56.65M | 55.97M |
| Revenue Growth % | - | -3.26% | 115.36% | 72.36% | 74.89% | 30.53% | 10.45% | 18.44% |
| Cost of Goods Sold | 1.68M | 1.44M | 3.64M | 5M | 6.26M | 8.33M | 8.31M | 8.41M |
| COGS % of Revenue | 26.9% | 23.79% | 27.92% | 22.25% | 15.92% | 16.25% | 14.67% | - |
| Gross Profit | 4.57M▲ 0% | 4.61M▲ 0.9% | 9.4M▲ 103.7% | 17.47M▲ 85.9% | 33.04M▲ 89.1% | 42.96M▲ 30.0% | 48.34M▲ 12.5% | 47.56M▲ 0% |
| Gross Margin % | 73.1% | 76.21% | 72.08% | 77.75% | 84.08% | 83.75% | 85.33% | 84.97% |
| Gross Profit Growth % | - | 0.85% | 103.69% | 85.93% | 89.12% | 30.02% | 12.53% | - |
| Operating Expenses | 14.77M | 16.13M | 35.36M | 60M | 76.14M | 102.45M | 99.61M | 97.91M |
| OpEx % of Revenue | 236.02% | 266.43% | 271.28% | 267.02% | 193.77% | 199.73% | 175.82% | - |
| Selling, General & Admin | 6.11M | 9.72M | 27.86M | 50.05M | 64.51M | 91.32M | 88.47M | 86.98M |
| SG&A % of Revenue | 97.59% | 160.53% | 213.74% | 222.73% | 164.17% | 178.03% | 156.17% | - |
| Research & Development | 8.66M | 6.41M | 7.5M | 9.95M | 11.63M | 11.13M | 11.13M | 10.94M |
| R&D % of Revenue | 138.44% | 105.9% | 57.54% | 44.29% | 29.6% | 21.7% | 19.65% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.19M▲ 0% | -11.51M▼ 12.9% | -25.97M▼ 125.5% | -42.53M▼ 63.8% | -43.1M▼ 1.4% | -59.49M▼ 38.0% | -51.27M▲ 13.8% | -50.35M▲ 0% |
| Operating Margin % | -162.92% | -190.22% | -199.2% | -189.27% | -109.69% | -115.98% | -90.49% | -89.97% |
| Operating Income Growth % | - | -12.95% | -125.53% | -63.77% | -1.35% | -38.02% | 13.83% | - |
| EBITDA | -10.14M | -11.44M | -25.8M | -42.12M | -42.58M | -58.87M | -51.27M | -49.61M |
| EBITDA Margin % | -162.03% | -188.98% | -197.91% | -187.44% | -108.36% | -114.78% | -90.49% | -88.63% |
| EBITDA Growth % | - | -12.83% | -125.54% | -63.24% | -1.11% | -38.26% | 12.92% | 14.92% |
| D&A (Non-Cash Add-back) | 56K | 75K | 168K | 412K | 522K | 619K | 0 | 748K |
| EBIT | -12.84M | -11.55M | -40.77M | -41.15M | -39.25M | -55.51M | -51.27M | -46.17M |
| Net Interest Income | -1.72M | -2.47M | -2.22M | -165K | -1.8M | -4.4M | -5.83M | -5.93M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.72M | 2.47M | 2.22M | 165K | 1.8M | 4.4M | 5.83M | 5.93M |
| Other Income/Expense | -4.37M | -2.51M | -17.02M | 1.21M | 2.05M | -420K | -2.06M | -1.75M |
| Pretax Income | -14.56M▲ 0% | -14.02M▲ 3.7% | -42.99M▼ 206.5% | -41.32M▲ 3.9% | -41.05M▲ 0.6% | -59.91M▼ 45.9% | -53.32M▲ 11.0% | -52.1M▲ 0% |
| Pretax Margin % | -232.7% | -231.69% | -329.76% | -183.89% | -104.47% | -116.8% | -94.13% | -93.1% |
| Income Tax | 73K | 85K | 91K | 109K | 147K | 55K | 18K | -82K |
| Effective Tax Rate % | -0.5% | -0.61% | -0.21% | -0.26% | -0.36% | -0.09% | -0.03% | 0.16% |
| Net Income | -14.63M▲ 0% | -14.11M▲ 3.6% | -43.08M▼ 205.3% | -41.43M▲ 3.8% | -41.2M▲ 0.6% | -59.97M▼ 45.5% | -53.31M▲ 11.1% | -52.02M▲ 0% |
| Net Margin % | -233.87% | -233.09% | -330.45% | -184.38% | -104.85% | -116.91% | -94.1% | -92.95% |
| Net Income Growth % | - | 3.58% | -205.32% | 3.83% | 0.55% | -45.55% | 11.1% | 11.04% |
| Net Income (Continuing) | -14.63M | -14.11M | -43.08M | -41.43M | -41.2M | -59.97M | -53.34M | -52.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.76▲ 0% | -0.73▲ 3.9% | -2.11▼ 189.0% | -2.02▲ 4.3% | -1.99▲ 1.5% | -2.65▼ 33.2% | -2.04▲ 23.0% | -1.99▲ 0% |
| EPS Growth % | - | 3.95% | -189.04% | 4.27% | 1.49% | -33.17% | 23.02% | 25.19% |
| EPS (Basic) | -0.76 | -0.73 | -2.11 | -2.02 | -1.99 | -2.65 | -2.04 | - |
| Diluted Shares Outstanding | 482.58K | 387.08K | 20.72M | 20.53M | 20.75M | 22.6M | 26.08M | 26.17M |
| Basic Shares Outstanding | 482.58K | 387.08K | 20.72M | 20.51M | 20.7M | 22.6M | 26.08M | 26.17M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
CVRX Balance Sheet
CVRx, Inc. (CVRX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 28.91M | 64.34M | 151.1M | 122.88M | 112.09M | 129.81M | 101.65M | 107.89M |
| Cash & Short-Term Investments | 25.74M | 59.11M | 142.07M | 106.19M | 90.57M | 105.93M | 75.71M | 85.12M |
| Cash Only | 25.74M | 59.11M | 142.07M | 106.19M | 90.57M | 105.93M | 75.71M | 85.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 719K | 1.28M | 2.56M | 5.5M | 7.55M | 9.27M | 10.66M | 8.21M |
| Days Sales Outstanding | 41.94 | 77.25 | 71.68 | 89.41 | 70.14 | 65.95 | 68.71 | 54.85 |
| Inventory | 2.07M | 3.34M | 3.88M | 6.96M | 10.98M | 12.11M | 12.21M | 11.39M |
| Days Inventory Outstanding | 449.36 | 847.36 | 389.07 | 507.96 | 640.79 | 530.24 | 536.02 | 508.74 |
| Other Current Assets | 0 | 0 | 2.58M | 4.22M | 2.99M | 2.5M | 3.07M | 3.16M |
| Total Non-Current Assets | 200K | 436K | 1.45M | 2.06M | 3.14M | 3.6M | 3.15M | 3.44M |
| Property, Plant & Equipment | 174K | 410K | 1.43M | 2.03M | 3.11M | 3.57M | 3.12M | 3.41M |
| Fixed Asset Turnover | 35.96x | 14.76x | 9.15x | 11.06x | 12.63x | 14.35x | 18.15x | 16.22x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 26K | 26K | 26K | 27K | 27K | 27K | 26K | 105K |
| Total Assets | 29.11M▲ 0% | 64.78M▲ 122.5% | 152.55M▲ 135.5% | 124.94M▼ 18.1% | 115.23M▼ 7.8% | 133.41M▲ 15.8% | 104.79M▼ 21.5% | 111.33M▲ 0% |
| Asset Turnover | 0.21x | 0.09x | 0.09x | 0.18x | 0.34x | 0.38x | 0.54x | 0.45x |
| Asset Growth % | - | 122.55% | 135.5% | -18.1% | -7.77% | 15.78% | -21.45% | 49.6% |
| Total Current Liabilities | 8.61M | 7.98M | 5.91M | 8.09M | 7.86M | 10.76M | 13.32M | 11.22M |
| Accounts Payable | 437K | 483K | 510K | 1.72M | 1.88M | 2.58M | 3.83M | 3.63M |
| Days Payables Outstanding | 94.77 | 122.43 | 51.14 | 125.51 | 109.92 | 113.08 | 168.34 | 130.11 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.54M | 5.26M | 2.32M | 3.26M | 4.11M | 5.67M | 9.48M | 7.25M |
| Current Ratio | 3.36x | 8.07x | 25.57x | 15.19x | 14.25x | 12.06x | 7.63x | 7.63x |
| Quick Ratio | 3.12x | 7.65x | 24.92x | 14.33x | 12.86x | 10.94x | 6.72x | 6.72x |
| Cash Conversion Cycle | 396.53 | 802.18 | 409.6 | 471.86 | 601.01 | 483.11 | 436.39 | 433.48 |
| Total Non-Current Liabilities | 299.54M | 350.04M | 681K | 7.67M | 31.42M | 51.6M | 52.15M | 52.05M |
| Long-Term Debt | 18.99M | 19.28M | 0 | 6.75M | 29.22M | 49.27M | 50.15M | 50.18M |
| Capital Lease Obligations | 0 | 0 | 0 | 117K | 1.16M | 877K | 638K | 3.23M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 280.54M | 330.76M | 681K | 805K | 1.04M | 1.45M | 1.36M | 6.63M |
| Total Liabilities | 308.15M | 358.01M | 6.59M | 15.76M | 39.28M | 62.36M | 65.47M | 63.27M |
| Total Debt | 18.99M | 19.28M | 0 | 7.09M | 30.61M | 50.43M | 50.79M | 50.18M |
| Net Debt | -6.75M | -39.83M | -142.07M | -99.11M | -59.96M | -55.5M | -24.92M | -34.94M |
| Debt / Equity | - | - | - | 0.06x | 0.40x | 0.71x | 1.29x | 1.29x |
| Debt / EBITDA | - | - | - | - | - | - | - | -1.01x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | 0.70x |
| Interest Coverage | -5.93x | -4.66x | -11.70x | -257.74x | -23.96x | -13.53x | -8.80x | -7.79x |
| Total Equity | -279.04M▲ 0% | -293.24M▼ 5.1% | 145.96M▲ 149.8% | 109.18M▼ 25.2% | 75.95M▼ 30.4% | 71.06M▼ 6.4% | 39.32M▼ 44.7% | 48.05M▲ 0% |
| Equity Growth % | - | -5.09% | 149.77% | -25.2% | -30.44% | -6.44% | -44.66% | -23.18% |
| Book Value per Share | -578.23 | -757.56 | 7.04 | 5.32 | 3.66 | 3.14 | 1.51 | 1.84 |
| Total Shareholders' Equity | -279.04M | -293.24M | 145.96M | 109.18M | 75.95M | 71.06M | 39.32M | 48.05M |
| Common Stock | 5K | 4K | 204K | 207K | 209K | 253K | 263K | 262K |
| Retained Earnings | -337.57M | -351.68M | -394.75M | -436.18M | -477.38M | -537.35M | -590.65M | -578.72M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -189K | -190K | -198K | -207K | -207K | -206K | -203K | -204K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CVRX Cash Flow Statement
CVRx, Inc. (CVRX) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -12.79M | -16.1M | -27.73M | -42.68M | -39.02M | -39.14M | -40.17M | -40.17M |
| Operating CF Margin % | -204.33% | -265.92% | -212.73% | -189.94% | -99.3% | -76.32% | -70.91% | - |
| Operating CF Growth % | - | -25.9% | -72.29% | -53.89% | 8.57% | -0.32% | -2.62% | 6.67% |
| Net Income | -14.63M | -14.11M | -43.08M | -41.43M | -41.2M | -59.97M | -53.31M | -52.02M |
| Depreciation & Amortization | 56K | 75K | 168K | 412K | 522K | 619K | 756K | 555K |
| Stock-Based Compensation | 66K | 132K | 1.91M | 3.89M | 6.3M | 19.05M | 11.05M | 8.06M |
| Deferred Taxes | 0 | 0 | 14.62M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.06M | 657K | 229K | 25K | 158K | 203K | 1.33M | 3.32M |
| Working Capital Changes | -1.33M | -2.85M | -1.58M | -5.57M | -4.8M | 949K | 0 | 1.67M |
| Change in Receivables | -183K | -562K | -1.28M | -2.94M | -2.05M | -1.72M | -1.4M | 824K |
| Change in Inventory | -216K | -1.27M | -537K | -3.08M | -4.03M | -1.12M | -98K | 498K |
| Change in Payables | -1.05M | 46K | 27K | 1.21M | 165K | 698K | 1.25M | 352K |
| Cash from Investing | -106K | -311K | -1.18M | -685K | -591K | -1.36M | -580K | -564K |
| Capital Expenditures | -106K | -311K | -1.18M | -685K | -591K | -1.36M | -580K | -564K |
| CapEx % of Revenue | 1.69% | 5.14% | 9.07% | 3.05% | 1.5% | 2.65% | 1.02% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 29.55M | 49.78M | 111.88M | 7.49M | 23.98M | 55.87M | 10.52M | 23.94M |
| Debt Issued (Net) | 5.34M | 0 | -21.3M | 7.5M | 22.5M | 20M | 0 | -19.85M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 0 | 2.49M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -1K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -478K | 0 | 23K | -7K | 1.48M | 3.35M | 10.52M | 21.33M |
| Net Change in Cash | 16.65M▲ 0% | 33.37M▲ 100.4% | 82.96M▲ 148.6% | -35.88M▼ 143.2% | -15.63M▲ 56.4% | 15.36M▲ 198.3% | -30.23M▼ 296.7% | -15.04M▲ 0% |
| Free Cash Flow | -12.89M▲ 0% | -16.41M▼ 27.3% | -28.91M▼ 76.2% | -43.36M▼ 50.0% | -39.61M▲ 8.6% | -40.51M▼ 2.3% | -40.75M▼ 0.6% | -38.98M▲ 0% |
| FCF Margin % | -206.03% | -271.06% | -221.81% | -192.99% | -100.81% | -78.97% | -71.93% | -69.65% |
| FCF Growth % | - | -27.27% | -76.24% | -49.96% | 8.65% | -2.25% | -0.6% | 3.63% |
| FCF per Share | -26.71 | -42.39 | -1.40 | -2.11 | -1.91 | -1.79 | -1.56 | -1.56 |
| FCF Conversion (FCF/Net Income) | 0.87x | 1.14x | 0.64x | 1.03x | 0.95x | 0.65x | 0.75x | 0.75x |
| Interest Paid | 1.22M | 2.03M | 1.71M | 59K | 1.4M | 0 | 0 | 1.16M |
| Taxes Paid | 15K | 10K | 2K | 5K | 4K | 0 | 0 | 0 |
CVRX Key Ratios
CVRx, Inc. (CVRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -29.51% | -32.47% | -44.51% | -81.58% | -96.59% | -108.26% |
| Return on Invested Capital (ROIC) | - | -501.05% | -456.98% | -248.07% | -282.88% | -256.67% | -256.67% |
| Gross Margin | 76.21% | 72.08% | 77.75% | 84.08% | 83.75% | 85.33% | 84.97% |
| Net Margin | -233.09% | -330.45% | -184.38% | -104.85% | -116.91% | -94.1% | -92.95% |
| Debt / Equity | - | - | 0.06x | 0.40x | 0.71x | 1.29x | 1.29x |
| Interest Coverage | -4.66x | -11.70x | -257.74x | -23.96x | -13.53x | -8.80x | -7.79x |
| FCF Conversion | 1.14x | 0.64x | 1.03x | 0.95x | 0.65x | 0.75x | 0.75x |
| Revenue Growth | -3.26% | 115.36% | 72.36% | 74.89% | 30.53% | 10.45% | 18.44% |
CVRX SEC Filings & Documents
CVRx, Inc. (CVRX) SEC filings — annual & quarterly reports (10-K, 10-Q)
CVRX Frequently Asked Questions
CVRx, Inc. (CVRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
CVRx, Inc. (CVRX) reported $56.0M in revenue for fiscal year 2025. This represents a 795% increase from $6.3M in 2019.
CVRx, Inc. (CVRX) grew revenue by 10.4% over the past year. This is steady growth.
CVRx, Inc. (CVRX) reported a net loss of $52.0M for fiscal year 2025.
Dividend & Returns
CVRx, Inc. (CVRX) has a return on equity (ROE) of -96.6%. Negative ROE indicates the company is unprofitable.
CVRx, Inc. (CVRX) had negative free cash flow of $39.0M in fiscal year 2025, likely due to heavy capital investments.
Explore More CVRX
CVRx, Inc. (CVRX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates